BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 16923621)

  • 1. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD.
    Stratelis G; Mölstad S; Jakobsson P; Zetterström O
    Scand J Prim Health Care; 2006 Sep; 24(3):133-9. PubMed ID: 16923621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are systematic consultation invitations and spirometry in general practice useful in the prevention of COPD among smokers?].
    Hansen KV; Dibbern H; Bentzon A
    Ugeskr Laeger; 2008 Dec; 170(50):4121-3. PubMed ID: 19091190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Productive cough is an independent risk factor for the development of COPD in former smokers.
    Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
    Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany.
    Gingter C; Wilm S; Abholz HH
    Fam Pract; 2009 Feb; 26(1):3-9. PubMed ID: 19033180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung function testing influences the attitude toward smoking cessation.
    Sundblad BM; Larsson K; Nathell L
    Nicotine Tob Res; 2010 Jan; 12(1):37-42. PubMed ID: 19926685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comments on screening spirometry for detection of COPD].
    van den Berg JW; van der Molen T; Kerstjens HA; Quanjer PH
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1557-60. PubMed ID: 17715762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease].
    Løkke A; Christensen LB; Fuglsang C
    Ugeskr Laeger; 2009 Oct; 171(43):3083-8. PubMed ID: 19852895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
    Kałucka S
    Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
    Kotz D; Huibers MJ; West RJ; Wesseling G; van Schayck OC
    Patient Educ Couns; 2009 Jul; 76(1):16-24. PubMed ID: 19150590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical analysis of the justifiability of labelling with COPD for smoking cessation.
    Kotz D; Vos R; Huibers MJ
    J Med Ethics; 2009 Sep; 35(9):534-40. PubMed ID: 19717691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
    Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
    Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
    Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
    Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low awareness of COPD among physicians.
    Sundblad BM; Larsson K; Nathell L
    Clin Respir J; 2008 Jan; 2(1):11-6. PubMed ID: 20298299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.